Information about Massachusetts' breast density notification legislation.
Recipient: Patients with dense breasts.
Notification text: Should include: the patient's mammogram shows dense breast tissue; dense breast tissue is common and not abnormal, but may increase the risk of breast cancer; dense breast tissue can make it difficult to find cancer on a mammogram and sometimes additional testing is needed for reliable breast screening; whether or not the interpreting physician determines additional testing is recommended; the patient's right to discuss the results of the mammogram with the interpreting radiologist or physician; a report of the mammogram has been sent to the referring physician and will become part of the patient's medical record.
Legislation: H.3733
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.